J&J's first-quarter profit beats estimates even as Stelara sales fall more than expected [CNBC]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: CNBC
Johnson & Johnson reported first-quarter earnings that beat Wall Street expectations on Tuesday and raised its full-year forecast, as strong demand for the cancer drug Darzalex and the psoriasis treatment Tremfya more ?than offset a steep falloff in ?sales of its blockbuster ?autoimmune drug Stelara. The drug and device maker reported first-quarter revenue of $24.1 billion, up nearly 10% from a year earlier. That exceeded analysts' estimates of $23.6 billion, according to LSEG data. Adjusted earnings came ?in ?at $2.70 per share, above the consensus estimate of $2.66. Stelara, which topped $10 ?billion in annual sales at its peak, is facing biosimilar competition after losing patent protection last year. Sales of the drug fell around 60% from a year ago to $656 million. Chief Financial Officer Joseph Wolk said in an interview that instead of switching to biosimilars, many patients have chosen other treatments such as Tremfya. “We are seeing increased share in Tremfya and we a
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Grasp Technologies Appoints Maria Chevalier as Chief Executive Officer [Yahoo! Finance Canada]Yahoo! Finance Canada
- Johnson & Johnson raises 2026 outlook after strong Q1 earnings [Yahoo! Finance]Yahoo! Finance
- Watch CNBC's full interview with Johnson & Johnson CFO Joseph Wolk [CNBC]CNBC
- Johnson & Johnson: Q1 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson reports Q1 2026 results, raises 2026 outlook [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/14/26 - Beat
JNJ
Sec Filings
- 4/14/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 13F-HR/A
- JNJ's page on the SEC website